by Suzanne Gaunt | Jun 10, 2025 | Long Covid
The Immune Response to SARS-CoV-2 and Long COVID Long COVID is currently reported to affect as many as one in five individuals who have had a COVID infection in the UK, with each new SARS-CoV-2 infection adding to the risk burden of developing the debilitating...
by Suzanne Gaunt | Apr 9, 2025 | Long Covid
EXETER, UK – 4 April 2025 – Attomarker, a leader in rapid diagnostic technology, today announced its plans for a new study evaluating the use of AstraZeneca’s monoclonal antibody, Sipavibart (Kavigale), as a potential treatment for long COVID patients. Long COVID...
by Suzanne Gaunt | Mar 13, 2025 | Long Covid
International Long COVID Awareness Day 2025 Five Years On, Long COVID Patients Are Still Being Left Behind On 15th March we mark five years since the start of the pandemic and with it, International Long COVID Awareness Day. While COVID-19 may have faded from...
